arbonate for patients at increased risk of contrast-induced
nephropathy (CIN) undergoing EVAR.
Level of recommendation

1 (Strong)

Quality of evidence

A (High)

We recommend holding metformin at the time of
administration of contrast material among patients
with an estimated glomerular Ô¨Åltration rate (eGFR)
of <60 mL/min or up to 48 hours before administration
of contrast material if the eGFR is <45